Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xenon Pharmaceuticals Inc. | Director | Common Shares | 23.6K | $968K | $41.05 | Nov 22, 2024 | Direct |
Xenon Pharmaceuticals Inc. | Director | Common Shares | 4.9K | $201K | $41.05 | Nov 22, 2024 | Indirect |
Xenon Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 0 | Nov 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XENE | Xenon Pharmaceuticals Inc. | Nov 22, 2024 | 8 | -$201K | 4 | Nov 22, 2024 | Director |
XENE | Xenon Pharmaceuticals Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
XENE | Xenon Pharmaceuticals Inc. | Dec 13, 2023 | 1 | -$312K | 4/A | Dec 15, 2023 | Director |
XENE | Xenon Pharmaceuticals Inc. | Jun 2, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
XENE | Xenon Pharmaceuticals Inc. | Nov 23, 2022 | 5 | -$137K | 4 | Nov 28, 2022 | Director |
XENE | Xenon Pharmaceuticals Inc. | Jun 28, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
XENE | Xenon Pharmaceuticals Inc. | Dec 8, 2021 | 2 | $7.55K | 4 | Dec 10, 2021 | Director |
XENE | Xenon Pharmaceuticals Inc. | Mar 17, 2021 | 2 | $1.95K | 4 | Jun 4, 2021 | Director |